French Govt Battles With Health Budget

29 September 1996

Health cost control has been at the heart of France's new finance bill for 1997, which has generated a nationwide debate on a variety of fronts.

The social action and health budgets together will rise 3.1% to 69.5 billion French francs ($13.54 billion). Within this total, the health allocation will fall 1.5% to 8.1 billion francs but, due to a lower wages bill, intervention credits will rise 4% and be used to fund major campaigns, eg against drug abuse (694 million francs, up 8.5%), AIDS, (474 million francs, up 5.3%) and alcohol/tobacco abuse (183 million francs). The drug agency's budget goes up from 67 million francs to 72.6 million francs ($14.1 million).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight